Hahn, M.M.; Triplett, C.A.; Anderson, M.S.; Smart, J.I.; Litherland, K.; Keech, S.; von Siebenthal, F.; Jones, M.; Phipps, A.J.; Henning, L.N.
Ceftobiprole Medocaril Is an Effective Post-Exposure Treatment in the Fischer 344 Rat Model of Pneumonic Tularemia. Antibiotics 2023, 12, 1337.
https://doi.org/10.3390/antibiotics12081337
AMA Style
Hahn MM, Triplett CA, Anderson MS, Smart JI, Litherland K, Keech S, von Siebenthal F, Jones M, Phipps AJ, Henning LN.
Ceftobiprole Medocaril Is an Effective Post-Exposure Treatment in the Fischer 344 Rat Model of Pneumonic Tularemia. Antibiotics. 2023; 12(8):1337.
https://doi.org/10.3390/antibiotics12081337
Chicago/Turabian Style
Hahn, Mark M., Cheryl A. Triplett, Michael S. Anderson, Jennifer I. Smart, Karine Litherland, Stephen Keech, Franziska von Siebenthal, Mark Jones, Andrew J. Phipps, and Lisa N. Henning.
2023. "Ceftobiprole Medocaril Is an Effective Post-Exposure Treatment in the Fischer 344 Rat Model of Pneumonic Tularemia" Antibiotics 12, no. 8: 1337.
https://doi.org/10.3390/antibiotics12081337
APA Style
Hahn, M. M., Triplett, C. A., Anderson, M. S., Smart, J. I., Litherland, K., Keech, S., von Siebenthal, F., Jones, M., Phipps, A. J., & Henning, L. N.
(2023). Ceftobiprole Medocaril Is an Effective Post-Exposure Treatment in the Fischer 344 Rat Model of Pneumonic Tularemia. Antibiotics, 12(8), 1337.
https://doi.org/10.3390/antibiotics12081337
